CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 162 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $57 | -34.5% | 4,200 | -25.0% | 0.01% | -50.0% |
| Q2 2023 | $87 | +112.2% | 5,600 | +93.1% | 0.01% | +140.0% |
| Q1 2023 | $41 | +2.5% | 2,900 | -71.7% | 0.01% | +66.7% |
| Q4 2022 | $40 | -99.9% | 10,233 | -0.9% | 0.00% | -25.0% |
| Q3 2022 | $45,000 | -81.9% | 10,323 | -75.4% | 0.00% | -77.8% |
| Q2 2022 | $248,000 | +74.6% | 42,000 | +371.9% | 0.02% | +125.0% |
| Q1 2022 | $142,000 | -54.0% | 8,900 | -44.7% | 0.01% | -38.5% |
| Q4 2021 | $309,000 | -50.6% | 16,100 | -56.5% | 0.01% | -53.6% |
| Q3 2021 | $626,000 | +198.1% | 37,000 | +487.3% | 0.03% | +180.0% |
| Q2 2021 | $210,000 | – | 6,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 2,600,000 | $88,218,000 | 12.13% |
| Octagon Capital Advisors LP | 759,898 | $25,783,339 | 3.59% |
| TSP Capital Management Group, LLC | 251,895 | $8,546,800 | 3.08% |
| ACUTA CAPITAL PARTNERS, LLC | 122,343 | $4,151,098 | 2.81% |
| 5AM Venture Management, LLC | 310,270 | $10,527,461 | 2.62% |
| COMMODORE CAPITAL LP | 631,665 | $21,432,393 | 2.41% |
| RTW INVESTMENTS, LP | 3,463,201 | $117,506,410 | 2.24% |
| Eversept Partners, LP | 785,740 | $26,660,158 | 2.23% |
| Redmile Group, LLC | 1,696,004 | $57,545,416 | 2.21% |
| Affinity Asset Advisors, LLC | 87,031 | $2,952,962 | 1.03% |